|
| 1 | ALK 1 | Marker for ALK positive anaplastic large cell lymphoma and other ALK rearranged malignancies |
| 2 | Alpha Feto Protein | Marker for hepatocellular carcinoma and germ cell tumours |
| 3 | Alpha methyacyl CoA Racemase AMACR | Marker for prostate carcinoma and other cancers |
| 4 | Arginase 1 | Marker for hepatocellular differentiation |
| 5 | Bcl 2 | Anti apoptotic marker used in lymphomas and other malignancies |
| 6 | Bcl 6 | Marker for follicular lymphomas and other B cell malignancies |
| 7 | Ber EP 4 | Marker for epithelial origin tumours |
| 8 | Beta Catenin | Marker for Want signalling pathway used in colon and other carcinomas |
| 9 | Beta HCG | Marker for trophoblastic tumours and some germ cell tumours |
| 10 | Bond Solution APES | Adhesive solution for coating slides in immunohistochemistry |
| 11 | Brachyury | Marker for chordoma and other tumours |
| 12 | CA 125 | Marker for ovarian carcinoma |
| 13 | CA 19 9 | Marker for pancreatic and gastrointestinal malignancies |
| 14 | Calcitonin | Marker for medullary thyroid carcinoma |
| 15 | Calretinin | Marker for mesothelioma and other tumours |
| 16 | Caldesmon | Marker for smooth muscle differentiation |
| 17 | Cam 5 2 | Cytokeratin marker for epithelial tissues |
| 18 | CD1a | Marker for Langerhans cell histiocytosis |
| 19 | Sox 9 | Marker for Cartilege Tummer |
| 20 | CD3 | T cell marker used in lymphoma diagnostics |
| 21 | CD5 | Marker for T cell and some B cell lymphomas |
| 22 | CD10 | Marker for follicular lymphoma and other malignancies |
| 23 | CD14 | Marker for monocyte macrophage lineage |
| 24 | CD15 | Marker for Hodgkin lymphoma and other malignancies |
| 25 | CD19 | B cell marker used in leukaemia and lymphoma diagnostics |
| 26 | CD20 | B cell marker for lymphomas and leukaemia s |
| 27 | CD21 | Marker for follicular dendritic cells |
| 28 | CD23 | Marker for chronic lymphocytic leukaemia and follicular dendritic cells |
| 29 | CD30 | Marker for Hodgkin lymphoma and anaplastic large cell lymphoma |
| 30 | CD31 | Marker for vascular endothelium |
| 31 | CD34 | Marker for hematopoietic stem cells and vascular endothelium |
| 32 | CD38 | Marker for plasma cells and B cell differentiation |
| 33 | CD41 | Marker for platelet precursors |
| 34 | CD45 LCA | Leukocyte common antigen marker for hematopoietic cells |
| 35 | CD56 | Marker for NK cells and neural neuroendocrine tumours |
| 36 | CD61 | Marker for megakaryocytes and platelets |
| 37 | CD68 | Marker for macrophages |
| 38 | CD79a | Marker for B cell lineage |
| 39 | CD99 | Marker for Ewing sarcoma and other small round cell tumours |
| 40 | CD117 | Marker for gastrointestinal stromal tumours GIST |
| 41 | CD138 | Marker for plasma cells |
| 42 | CDX 2 | Marker for gastrointestinal origin tumours |
| 43 | CDK4 | Marker for cell cycle regulation used in sarcomas |
| 44 | CDH17 | Marker for gastrointestinal tract differentiation |
| 45 | CEA Monoclonal | Marker for colorectal and other adenocarcinomas |
| 46 | CEA Polyclonal | Marker for colorectal and other adenocarcinomas |
| 47 | Chromogranin A | Marker for neuroendocrine tumours |
| 48 | CK5 6 | Cytokeratin marker for basal and squamous cell differentiation |
| 49 | CK7 | Cytokeratin marker for epithelial origin |
| 50 | CK14 | Marker for squamous cell differentiation |
| 51 | CK8 | Marker for simple epithelia |
| 52 | CK8 18 | Marker for epithelial differentiation |
| 53 | CK19 | Marker for colorectal and urothelial carcinoma |
| 54 | CK20 | Marker for colorectal and urothelial carcinoma |
| 55 | CK AE1 AE3 | Pan cytokeratin marker for epithelial origin tumours |
| 56 | Claudin 4 | Marker for epithelial tight junctions useful in distinguishing adenocarcinomas from mesotheliomas |
| 57 | Collagen IV | Marker for basement membrane integrity |
| 58 | Cyclin D1 | Marker for cell cycle regulation used in mantle cell lymphoma and other cancers |
| 59 | DAB Reagent | Chromogen reagent for visualization in IHC |
| 60 | Desmin | Marker for muscle differentiation |
| 61 | DOG1 | Marker for gastrointestinal stromal tumours GIST |
| 62 | E cadherin NCH 38 | Marker for epithelial cell adhesion used in differentiating carcinomas |
| 63 | EGFR | Marker for epidermal growth factor receptor associated with various cancers |
| 64 | EBV | Marker for Epstein Barr virus associated malignancies |
| 65 | EMA | Marker for epithelial membrane antigen used in carcinomas and other epithelial tumours |
| 66 | ER | Estrogen receptor marker used in breast and other hormone sensitive cancers |
| 67 | FOX L2 | Marker for granulosa cell tumours |
| 68 | GCDFP 15 | Marker for apocrine differentiation used in breast and salivary gland tumours |
| 69 | Glypican 3 | Marker for hepatocellular carcinoma |
| 70 | GATA 3 | Marker for breast and urothelial carcinomas |
| 71 | GFAP | Marker for astrocytes and glial cells |
| 72 | Hep Par 1 | Marker for hepatocellular differentiation |
| 73 | Her 2 neu | Marker for HER2 overexpression in breast and other cancers |
| 74 | HMB 45 | Marker for melanoma |
| 75 | HMW CK 34 E12 | High molecular weight cytokeratin marker for basal and squamous cell differentiation |
| 76 | Inhibin alpha | Marker for sex cord stromal tumours |
| 77 | INI1 | Marker for rhabdoid tumours and other malignancies |
| 78 | Kappa light chain | Marker for monoclonal B cell populations |
| 79 | Ki 67 | Proliferation marker used in grading malignancies |
| 80 | Lambda light chain | Marker for monoclonal B cell populations |
| 81 | Langerin | Marker for Langerhans cell histiocytosis |
| 82 | LIN28A | Marker for embryonal tumours |
| 83 | MPO Poluclonal | Marker for myeloid lineage used in leukaemia diagnostics |
| 84 | MSA Muscle Specific Actin | Marker for smooth muscle differentiation |
| 85 | Melan A | Marker for melanocytic tumours |
| 86 | MDM2 | Marker for liposarcoma and other malignancies |
| 87 | MLH1 | Marker for mismatch repair deficiency in tumours |
| 88 | MSH2 | Marker for mismatch repair deficiency in tumours |
| 89 | MSH6 | Marker for mismatch repair deficiency in tumours |
| 90 | Mammaglobin | Marker for breast carcinoma |
| 91 | MOC31 | Marker for epithelial tumours particularly carcinomas |
| 92 | MIB1 | Proliferation marker synonymous with Ki 67 |
| 93 | MUC1 | Marker for glandular epithelium and adenocarcinomas |
| 94 | MUC2 | Marker for goblet cells and mucinous tumours |
| 95 | MUC4 | Marker for certain adenocarcinomas including pancreas and lung |
| 96 | MUM1 | Marker for multiple myeloma and diffuse large B cell lymphoma |
| 97 | Myogenin | Marker for rhabdomyosarcoma |
| 98 | Novapen Pap pen Hydrophobic Slide Marker | Used for hydrophobic barrier creation on slides |
| 99 | Napsin A | Marker for lung adenocarcinoma |
| 100 | NANOG | Stem cell marker used in embryonal tumours |
| 101 | NUT | Marker for NUT midline carcinoma |
| 102 | NKX2 2 | Marker for Ewing sarcoma |
| 103 | NSE | Marker for neural and neuroendocrine differentiation |
| 104 | OCT 3 4 | Marker for embryonic stem cells and germ cell tumours |
| 105 | p16 | Tumour suppressor marker associated with HPV related cancers |
| 106 | p40 | Marker for squamous cell differentiation used in lung and head neck cancers |
| 107 | p53 | Tumour suppressor marker mutated in many cancers |
| 108 | p57 | Marker for trophoblastic diseases |
| 109 | p63 | Marker for squamous epithelium and myoepithelial cells |
| 110 | Placental Alkaline Phosphatase PLAP | Marker for germ cell tumours |
| 111 | PR | Progesterone receptor marker used in breast and endometrial cancers |
| 112 | Pax2 | Marker for renal and Mullerian origin tumours |
| 113 | Pax5 | Marker for B cell lineage used in lymphomas |
| 114 | Pax8 | Marker for renal thyroid and Mullerian origin tumours |
| 115 | Poly L Lysine | Coating agent for adhesion of tissue sections to slides |
| 116 | PSA | Marker for prostate specific antigen used in prostate cancer |
| 117 | PLAG1 | Marker for pleomorphic adenomas and related tumours |
| 118 | PMS2 | Marker for mismatch repair deficiency in tumours |
| 119 | SALL4 | Marker for germ cell tumours and embryonal tumours |
| 120 | SATB2 | Marker for colorectal cancer and other carcinomas |
| 121 | SF1 | Marker used in steroid hormone synthesis |
| 122 | SOX2 | Stem cell marker used in embryonic development and cancers |
| 123 | SOX10 | Marker for neural crest and melanocytic tumours |
| 124 | SMURF1 | Regulator of TGF beta signalling pathways |
| 125 | STAT 6 | Marker for IL 4 IL 13 mediated immune signalling |
| 126 | S 100 | Marker for melanoma and other neural neuroendocrine tumours |
| 127 | Secondary Kit New and Improved Super Sensitive Polymer HRP IHC Detection Kit 1St Generation | Includes 40ml H2O2 40ml HRP 40ml mouse linker 80ml DAB substrate buffer 2ml Chromogen 30ml x 3 Antigen retrieval solution concentrate 1L washing buffer concentrate 1St Generation |
| 128 | Secondary Kit New and Improved Super Sensitive Polymer HRP IHC Detection Kit 2nd Generation | Includes 40ml H2O2 40ml HRP 40ml mouse linker 80ml DAB substrate buffer 2ml Chromogen 30ml x 3 Antigen retrieval solution concentrate 1L washing buffer concentrate 2ND Generation |
| 129 | Secondary Kit New and Improved Super Sensitive Polymer HRP IHC Detection Kit 3rd Generation | Includes 40ml H2O2 40ml HRP 40ml mouse linker 80ml DAB substrate buffer 2ml Chromogen 30ml x 3 Antigen retrieval solution concentrate 1L washing buffer concentrate 3RD Generation |
| 130 | SMA | Smooth muscle actin marker used in mesenchymal and myogenic tumours |
| 131 | Smoothelin | Smooth muscle differentiation marker |
| 132 | Synaptophysin | Marker for neuroendocrine and neural differentiation |
| 133 | Tdt | Terminal deoxynucleotidyl transferase used in lymphoblastic leukaemia lymphoma |
| 134 | TFE 3 | Marker for transcription factor in specific cancers such as renal cell carcinoma |
| 135 | TLE 1 | Marker for synovial sarcoma |
| 136 | TTF 1 | Marker for thyroid and lung carcinomas |
| 137 | Vimentin | Marker for mesenchymal origin tumours |
| 138 | WT 1 | Marker for Wilms tumour and other cancers |
| 139 | Uroplakin 2 | Marker for urothelial differentiation |
| 140 | Uroplakin 3 | Marker for urothelial carcinoma |
| 141 | Wash Buffer | Concentrated solution for washing in IHC |
| 142 | Retrieval Solution | Solution for antigen retrieval during IHC |
| 143 | Rabbit Linker | Polymer linker for rabbit antibodies in IHC |
| 144 | Mouse Linker | Polymer linker for Mouse antibodies in IHC |
| 145 | Envision FLEX HRP | flex hrp magenta substrate chromogen system |
| 146 | Peroxidase Blocking Reagent | a highly stable form of hydrogen peroxide for blocking endogenous peroxidase |
| 147 | Substrate Buffer | Widely used in biochemical assays especially when alkaline phosphatase activity is to be measured |
| 148 | DAB plus Chromogen | as per discription in specification |
| 149 | IDH m and wild Type | IDH mutation in glioma has a unique effect on DNA methylome and transcriptome |
| 150 | oct 0 2 | Octamer Binding Transcription Factor 2 OCT2 |
| 151 | Atrx | define the molecular classification of gliomas |
| 152 | Digital pH Meter | Instrument for measuring pH accurately |
| 153 | Haematoxylin Stain | Nuclear stain for tissue sections |
| 154 | PD L1 IHC 22C3 pharmDx | Specific assay for detecting PD L1 in cancer tissues |
| 155 | Charged Slides | Positively charged slides for tissue adhesion |
| 156 | Diamond Marker Pen | Marker for writing on slides |
| 157 | Retrieval Chamber | Chamber for controlled heat based antigen retrieval |
| 158 | Humidity Chamber | Chamber for maintaining optimal humidity during staining |
| 159 | Polished Tissue Embedding Molds | as per discription in specification |
| 160 | Glass Slide Staining Rack Dual Clamp | as per discription in specification |
| 161 | Electronic Pressure Cooker Induction | Used for high pressure heat mediated antigen retrieval |
| 162 | Antibody Diluent | Buffer to dilute antibodies for IHC |
| 163 | Coated Slides | Pre treated slides for IHC applications |
| 164 | BSAP Pax 5 | PAX 5 in an immunohistochemical panel to diagnose lymphoid neoplasms of B cell origin |
| 165 | Cytok HMW 38 E12 | antibody promises to be a specific marker useful in differential identification of squamous carcinomas from adenocarcinomas |
| 166 | ERG EP110 | ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic |
| 167 | NKX3 1 | highly sensitive and specific tissue marker of metastatic prostatic adenocarcinoma |
